Analyst firms · UBS · HBAN
UBS HBAN price target and rating history
Huntington Bancshares Incorporated (HBAN) · Finance
UBS rates Huntington Bancshares Incorporated (HBAN) Buy with a $15 price target, as of its latest action on Feb 14, 2024. It has published 3 rating actions on HBAN since January 2022, including 1 upgrade and 1 downgrade. Across 6 firms with a HBAN price target in the last 12 months, the median target is $19.
- Current rating
- Buy
- Price target
- $15
- Median target, all firms
- $19
- Actions on HBAN
- 3
UBS price target on HBAN
Every UBS rating on HBAN
- Feb 14, 2024
- Apr 10, 2023DowngradeUBS downgrades to Neutral from Buy
- Jan 13, 2022
How other firms rate HBAN
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Wolfe Research | Peer Perform | Oct 27, 2026 | |
| TD Cowen | Buy | $18 | Oct 8, 2026 |
| Wells Fargo | Overweight | $23 | Aug 17, 2026 |
| BofA Securities | Neutral | $18.50 | Jul 27, 2026 |
| Morgan Stanley | Equal-Weight | $19 | Jul 24, 2026 |
| Jefferies | Hold | $19 | Jul 6, 2026 |
| Stephens | Equal-Weight | Jun 15, 2026 | |
| Evercore ISI | Outperform | $21 | Feb 3, 2026 |
Questions about UBS and HBAN
- What is UBS's price target for HBAN?
- UBS's latest stated price target for Huntington Bancshares Incorporated (HBAN) is $15, from its action on Feb 14, 2024.
- What is UBS's rating on HBAN?
- UBS rates HBAN Buy, a bullish rating, as of Feb 14, 2024.
- When did UBS last change its view on HBAN?
- On Feb 14, 2024, UBS upgrades to Buy from Neutral, price target $14 to $15.
- How does UBS's HBAN target compare with other analysts?
- Across 6 firms with a HBAN price target in the last 12 months, the median target is $19.
More HBAN rating histories
- Wolfe Research5
- BofA Securities3
- Morgan Stanley5
- Jefferies3
- Stephens3
- Evercore ISI3
- J.P. Morgan4
- Keefe, Bruyette & Woods3
- Raymond James4
All UBS ratingsHBAN news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.